ANTIMICROBIAL INNOVATION ALLIANCE

Lobbying client · District of Columbia · filed 2025 to 2025

Development of antimicrobial resistance policy to assist life sciences industry.

$0 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page is grouped by the client's LDA id (209985), not by name.

Firms hired 1

FORBES-TATE $0 4 filings

Reported by year 1 year

2025 $0 4 filings

Issues lobbied 1

Health Issues 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 4
SENATE 4

Recent filings 4 total

4T

FORBES-TATE

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · posted Jan 19, 2026

View → Q3

FORBES-TATE

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · posted Oct 19, 2025

View → Q2

FORBES-TATE

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · posted Jul 18, 2025

View → Q1

FORBES-TATE

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.